Surgical & Medical Instruments & Apparatus Industry - SEC Form 4 Insider Trading Screener
Manufacturing Sector - Specialty Instruments - Surgical & Medical Instruments & Apparatus
100 results - 
- 
- 
- 
- 
- 
- 
- - - - - - | TC | cnt | 1d | 1w | 1m | 6m |
X |
Filing Date |
Trade Date |
Ticker |
Company | Insider Name | Insider Title |
Trade Type |
Share Price |
Shares Traded |
Shares Owned |
Own chg |
Value Traded |
1d ret |
1w ret |
1m ret |
6m ret |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2018-04-19 | NVCR | Novocure Ltd | Palti Yoram | CTO | S - Sale | $24.98 | -49,362 | 1,217,620 | -4% | -$1,233,225 | |||||
| D | 2018-03-02 | ICUI | Icu Medical Inc/de | Swinney Robert S | Dir | S - Sale+OE | $245.00 | -698 | 16,033 | -4% | -$171,010 | |||||
| D | 2018-04-18 | NVCR | Novocure Ltd | Kirson Eilon D. | Chief Science Officer | S - Sale+OE | $24.00 | -147,825 | 39,582 | -79% | -$3,547,800 | |||||
| DM | 2018-04-18 | GMED | Globus Medical Inc | Demski David M | CEO | S - Sale+OE | $51.00 | -149,109 | 148,855 | -50% | -$7,604,564 | |||||
| D | 2018-04-18 | TCMD | Tactile Systems Technology Inc | Folkes Robert J. | COO | S - Sale+OE | $35.84 | -2,482 | 119,403 | -2% | -$88,958 | |||||
2018-04-18 | SYK | Stryker Corp | Owen Katherine Ann | VP, Strategy, IR | S - Sale | $165.00 | -2,651 | 8,607 | -24% | -$437,415 | ||||||
| DM | 2018-04-17 | NVCR | Novocure Ltd | Ambrogi Michael J. | COO | S - Sale+OE | $23.03 | -40,000 | 146,558 | -21% | -$921,240 | |||||
2018-04-16 | INO | Inovio Pharmaceuticals, Inc. | Weiner David B. | Dir | S - Sale | $4.91 | -9,000 | 758,956 | -1% | -$44,203 | ||||||
| M | 2018-04-17 | NVCR | Novocure Ltd | Palti Yoram | CTO | S - Sale | $23.65 | -44,072 | 1,266,982 | -3% | -$1,042,304 | |||||
2018-04-17 | CMD | Cantel Medical Corp | Clifford Peter G | EVP, CFO | S - Sale | $114.89 | -1,250 | 14,172 | -8% | -$143,615 | ||||||
| D | 2018-04-17 | CTSO | Cytosorbents Corp | Bloch Kathleen P. | CFO | S - Sale+OE | $8.25 | -120 | 262,304 | 0% | -$990 | |||||
2018-04-16 | DXCM | Dexcom Inc | Gregg Terrance H | Exec COB | S - Sale | $73.04 | -10,000 | 534,017 | -2% | -$730,414 | ||||||
| D | 2018-04-17 | CRY | Cryolife Inc | Davis John E | SVP, Global Sales | S - Sale+OE | $23.00 | -3,333 | 51,438 | -6% | -$76,659 | |||||
2018-04-18 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.89 | +1,760 | 17,698,191 | 0% | +$1,566 | ||||||
2018-04-16 | RMD | Resmed Inc | Sandercock Brett | CFO | S - Sale | $99.36 | -2,000 | 71,072 | -3% | -$198,720 | ||||||
| D | 2018-04-16 | XENT | Intersect Ent, Inc. | Earnhardt Lisa D | Pres, CEO | S - Sale+OE | $39.59 | -15,000 | 510,865 | -3% | -$593,918 | |||||
| D | 2018-04-16 | TFX | Teleflex Inc | Smith Benson | Dir | S - Sale+OE | $260.51 | -9,331 | 68,167 | -12% | -$2,430,868 | |||||
2018-04-16 | SYK | Stryker Corp | Boehnlein Glenn S | VP, CFO | S - Sale | $160.00 | -750 | 4,822 | -13% | -$120,000 | ||||||
2018-04-16 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.85 | +1,500 | 17,696,431 | 0% | +$1,283 | ||||||
2018-04-16 | CODX | Co-Diagnostics, Inc. | Satterfield Brent | Chief Science Officer, 10% | P - Purchase | $1.94 | +500 | 2,272,698 | 0% | +$970 | ||||||
| DM | 2018-04-12 | GMED | Globus Medical Inc | Demski David M | CEO | S - Sale+OE | $51.00 | -50,891 | 148,855 | -25% | -$2,595,441 | |||||
| D | 2018-04-12 | HRC | Hill-Rom Holdings, Inc. | Rasin Deborah | SVP, GC | S - Sale+OE | $86.02 | -7,590 | 10,233 | -43% | -$652,892 | |||||
2018-04-13 | KIDS | Orthopediatrics Corp | Throdahl Mark C | Pres, CEO | S - Sale | $17.92 | -27,549 | 141,651 | -16% | -$493,678 | ||||||
2018-04-13 | KIDS | Orthopediatrics Corp | Hite Fred | CFO | S - Sale | $17.92 | -29,471 | 47,529 | -38% | -$528,120 | ||||||
2018-04-13 | KIDS | Orthopediatrics Corp | Gerritzen Daniel J | GC, Secretary | S - Sale | $17.92 | -11,145 | 23,218 | -32% | -$199,718 | ||||||
2018-04-13 | KIDS | Orthopediatrics Corp | Odle Gregory A | EVP | S - Sale | $17.92 | -33,161 | 81,679 | -29% | -$594,245 | ||||||
2018-04-13 | KIDS | Orthopediatrics Corp | Bailey David R | EVP | S - Sale | $17.92 | -30,231 | 104,764 | -22% | -$541,740 | ||||||
2018-04-13 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.88 | +1,202 | 17,694,931 | 0% | +$1,055 | ||||||
| A | 2017-12-18 | CMD | Cantel Medical Corp | Fotiades George L | Dir | S - Sale | $101.08 | -5,400 | 94,666 | -5% | -$545,859 | |||||
| DM | 2018-04-12 | INO | Inovio Pharmaceuticals, Inc. | Kim Jong Joseph | CEO | S - Sale+OE | $5.10 | -211,250 | 4,148,653 | -5% | -$1,076,553 | |||||
| D | 2018-04-12 | INO | Inovio Pharmaceuticals, Inc. | Benito Simon X | Dir | S - Sale+OE | $5.23 | -3,750 | 27,798 | -12% | -$19,619 | |||||
2018-04-12 | GNMK | Genmark Diagnostics, Inc. | Stier Eric | SVP, GC | S - Sale | $5.46 | -10,000 | 197,502 | -5% | -$54,600 | ||||||
2018-04-12 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.87 | +6,590 | 17,693,729 | 0% | +$5,745 | ||||||
2018-04-10 | CMD | Cantel Medical Corp | Nodiff Eric W | EVP, GC | S - Sale | $108.31 | -1,275 | 39,556 | -3% | -$138,089 | ||||||
| D | 2018-04-10 | TCMD | Tactile Systems Technology Inc | Folkes Robert J. | COO | S - Sale+OE | $31.90 | -3,044 | 119,403 | -2% | -$97,109 | |||||
| D | 2018-04-10 | NEPH | Nephros Inc | Evans Daron | Pres, CEO | P - Purchase | $0.45 | +79,000 | 1,076,790 | +8% | +$35,550 | |||||
| D | 2018-04-10 | NEPH | Nephros Inc | Astor Andrew | CFO | P - Purchase | $0.45 | +80,000 | 420,459 | +23% | +$36,000 | |||||
2018-04-11 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.87 | +17,600 | 17,687,139 | 0% | +$15,324 | ||||||
| A | 2018-04-09 | CODX | Co-Diagnostics, Inc. | Satterfield Brent | Chief Science Officer, 10% | P - Purchase | $2.05 | +2,400 | 2,272,198 | 0% | +$4,920 | |||||
| DM | 2018-04-09 | GMED | Globus Medical Inc | Scavilla Daniel T | SVP, CFO | S - Sale+OE | $50.00 | -100,000 | 0 | -100% | -$5,000,031 | |||||
2018-04-10 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.88 | +6,500 | 17,669,539 | 0% | +$5,720 | ||||||
| M | 2017-07-19 | HAE | Haemonetics Corp | Goldstein Dan | VP, Corporate Controller | S - Sale | $54.65 | -518 | 3,681 | -12% | -$28,307 | |||||
| E | 2018-04-09 | CODX | Co-Diagnostics, Inc. | Satterfield Brent | Chief Science Officer, 10% | P - Purchase | $2.05 | +2,400 | 2,272,198 | 0% | +$4,920 | |||||
| D | 2018-04-09 | TFX | Teleflex Inc | Babich George Jr | Dir | S - Sale+OE | $246.87 | -2,500 | 8,583 | -23% | -$617,175 | |||||
2018-04-09 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.87 | +3,700 | 17,663,039 | 0% | +$3,216 | ||||||
2018-04-06 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.87 | +5,451 | 17,659,339 | 0% | +$4,754 | ||||||
2018-04-05 | ICUI | Icu Medical Inc/de | Lopez George A | Dir, 10% | S - Sale | $252.15 | -6,525 | 1,448,559 | 0% | -$1,645,301 | ||||||
| D | 2018-02-21 | CTSO | Cytosorbents Corp | Bloch Kathleen P. | CFO | S - Sale+OE | $8.00 | -10,000 | 267,870 | -4% | -$80,000 | |||||
2018-04-04 | NVCR | Novocure Ltd | Palti Yoram | CTO | S - Sale | $19.89 | -30,000 | 1,311,054 | -2% | -$596,754 | ||||||
2018-04-04 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.89 | +3,000 | 17,653,888 | 0% | +$2,670 | ||||||
| D | 2018-04-02 | TFX | Teleflex Inc | Smith Benson | Dir | S - Sale+OE | $251.49 | -9,331 | 78,380 | -11% | -$2,346,679 | |||||
| D | 2018-04-03 | RMD | Resmed Inc | Pendarvis David | Chief Administrative Officer | S - Sale+OE | $96.19 | -2,810 | 94,453 | -3% | -$270,294 | |||||
| D | 2018-04-03 | XENT | Intersect Ent, Inc. | Hilleman Jeryl L | CFO | S - Sale+OE | $37.66 | -12,833 | 23,432 | -35% | -$483,247 | |||||
| D | 2018-04-02 | BAX | Baxter International Inc | Stroucken Albert P L | Dir | S - Sale+OE | $64.75 | -3,760 | 25,316 | -13% | -$243,443 | |||||
| D | 2018-04-02 | BAX | Baxter International Inc | Hellman Peter S | Dir | S - Sale+OE | $64.74 | -3,760 | 22,322 | -14% | -$243,408 | |||||
| M | 2018-04-02 | ICUI | Icu Medical Inc/de | Lopez George A | Dir, 10% | S - Sale | $246.73 | -26,475 | 1,455,084 | -2% | -$6,532,196 | |||||
| M | 2018-04-02 | NVCR | Novocure Ltd | Palti Yoram | CTO | S - Sale | $20.32 | -60,000 | 1,341,054 | -4% | -$1,219,429 | |||||
2018-04-03 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.88 | +18,700 | 17,650,888 | 0% | +$16,430 | ||||||
2018-04-02 | RMD | Resmed Inc | Hollingshead James | Pres, Sleep Business | S - Sale | $98.19 | -600 | 59,940 | -1% | -$58,914 | ||||||
2018-04-03 | ARAY | Accuray Inc | Nouri Alaleh | SVP, GC, | S - Sale | $4.65 | -2,585 | 204,483 | -1% | -$12,020 | ||||||
2018-04-03 | ARAY | Accuray Inc | Waters Kevin | SVP, CFO | S - Sale | $4.65 | -2,997 | 328,260 | -1% | -$13,936 | ||||||
2018-04-03 | ARAY | Accuray Inc | Levine Joshua | Pres, CEO | S - Sale | $4.65 | -8,675 | 1,426,753 | -1% | -$40,339 | ||||||
| D | 2018-04-02 | BSX | Boston Scientific Corp | Pierce David A | EVP,Pres MedSurg | S - Sale+OE | $27.22 | -5,000 | 24,201 | -17% | -$136,125 | |||||
2018-03-29 | NVCR | Novocure Ltd | Palti Yoram | CTO | S - Sale | $21.67 | -30,000 | 1,401,054 | -2% | -$649,977 | ||||||
2018-03-15 | CASM | Cas Medical Systems Inc | Gamelin John | VP, R, D | S - Sale | $1.16 | -3,000 | 181,078 | -2% | -$3,489 | ||||||
| D | 2018-03-28 | BAX | Baxter International Inc | Storm Kornelis J. | Dir | S - Sale+OE | $64.64 | -47,959 | 22,512 | -68% | -$3,100,114 | |||||
| D | 2018-03-28 | BAX | Baxter International Inc | Gavin James R III | Dir | S - Sale+OE | $64.56 | -18,750 | 32,638 | -36% | -$1,210,498 | |||||
| D | 2018-03-28 | GMED | Globus Medical Inc | Schwartz Eric | SVP, GC | S - Sale+OE | $50.00 | -24,000 | 0 | -100% | -$1,200,000 | |||||
| M | 2018-03-27 | CMD | Cantel Medical Corp | Diker Charles M | COB, 10% | S - Sale | $111.69 | -11,900 | 3,681,511 | 0% | -$1,329,083 | |||||
2018-03-26 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.98 | +1,500 | 17,632,188 | 0% | +$1,472 | ||||||
2018-03-26 | SYK | Stryker Corp | Owen Katherine Ann | VP, Strategy, IR | S - Sale | $160.00 | -103 | 11,216 | -1% | -$16,480 | ||||||
2018-03-23 | DXCM | Dexcom Inc | Doubleday Richard | EVP, Chief Commercial Officer | S - Sale | $68.44 | -2,581 | 105,820 | -2% | -$176,643 | ||||||
| D | 2018-03-26 | TFX | Teleflex Inc | Babich George Jr | Dir | S - Sale+OE | $254.53 | -2,500 | 8,583 | -23% | -$636,325 | |||||
2018-03-23 | SYK | Stryker Corp | Owen Katherine Ann | VP, Strategy, IR | S - Sale | $160.23 | -2,572 | 11,319 | -19% | -$412,114 | ||||||
2018-03-23 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.99 | +8,000 | 17,630,688 | 0% | +$7,891 | ||||||
2018-03-22 | SYK | Stryker Corp | Lobo Kevin | COB, CEO | S - Sale | $162.90 | -39,808 | 49,887 | -44% | -$6,484,588 | ||||||
2018-03-22 | SYK | Stryker Corp | Becker Yin C | VP, Comm., Public Affairs | S - Sale | $162.90 | -3,848 | 10,761 | -26% | -$626,832 | ||||||
2018-03-20 | TCMD | Tactile Systems Technology Inc | Rishe Bryan | SVP, Sales | S - Sale | $31.02 | -1,500 | 91,085 | -2% | -$46,530 | ||||||
2018-03-20 | BSX | Boston Scientific Corp | Sorenson John Bradley | SVP, Manuf, Sup Chn | S - Sale | $27.63 | -2,200 | 34,636 | -6% | -$60,786 | ||||||
| M | 2018-03-19 | ICUI | Icu Medical Inc/de | Lopez George A | Dir, 10% | S - Sale | $251.37 | -33,000 | 1,481,559 | -2% | -$8,295,307 | |||||
2018-03-16 | IRMD | Iradimed Corp | Susi Roger E. | CEO, Pres, COB, 10% | P - Purchase | $13.85 | +1,000 | 5,821,000 | 0% | +$13,850 | ||||||
| D | 2018-03-19 | BSX | Boston Scientific Corp | Brennan Daniel J. | EVP, CFO | S - Sale+OE | $27.87 | -60,209 | 279,183 | -18% | -$1,678,013 | |||||
2018-03-16 | PODD | Insulet Corp | Thomas Bradley A | EVP HR | S - Sale | $85.00 | -3,500 | 66,828 | -5% | -$297,500 | ||||||
| D | 2018-03-16 | TCMD | Tactile Systems Technology Inc | Folkes Robert J. | COO | S - Sale+OE | $31.80 | -2,482 | 119,403 | -2% | -$78,928 | |||||
| M | 2018-03-16 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.97 | +4,000 | 17,613,188 | 0% | +$3,882 | |||||
2018-03-16 | IVTY | Invuity, Inc. | Flora Scott D | Interim Pres, CEO | P - Purchase | $3.90 | +25,281 | 77,203 | +49% | +$98,480 | ||||||
2018-03-16 | IVTY | Invuity, Inc. | Mackaness James H | CFO | P - Purchase | $3.90 | +2,528 | 44,399 | +6% | +$9,848 | ||||||
2018-03-16 | IVTY | Invuity, Inc. | Fish Marcia | CHRO | P - Purchase | $3.90 | +2,528 | 11,228 | +29% | +$9,848 | ||||||
2018-03-16 | IVTY | Invuity, Inc. | Roberts Eric W | Dir | P - Purchase | $3.90 | +25,281 | 151,295 | +20% | +$98,480 | ||||||
2018-03-16 | IVTY | Invuity, Inc. | Lipps Randall A | Dir | P - Purchase | $3.90 | +10,112 | 89,159 | +13% | +$39,390 | ||||||
2018-03-16 | IVTY | Invuity, Inc. | Sale Andrew | SVP Global Sales | P - Purchase | $3.90 | +8,848 | 28,793 | +44% | +$34,466 | ||||||
2018-03-16 | IVTY | Invuity, Inc. | Lucier Gregory T | Dir | P - Purchase | $3.90 | +64,158 | 135,449 | +90% | +$249,921 | ||||||
2018-03-15 | DXCM | Dexcom Inc | Gregg Terrance H | Exec COB | S - Sale | $65.51 | -10,000 | 544,017 | -2% | -$655,122 | ||||||
| M | 2018-03-15 | IRMD | Iradimed Corp | Waldman Louis S. | Controller | S - Sale | $13.83 | -30,000 | 65,221 | -32% | -$415,026 | |||||
| D | 2018-03-15 | SYK | Stryker Corp | Floyd David | Group Pres | S - Sale+OE | $166.58 | -55,119 | 22,103 | -71% | -$9,181,844 | |||||
2018-03-15 | OBLN | Obalon Therapeutics Inc | Drake Neil | VP Research, Development | P - Purchase | $3.96 | +5,000 | 26,850 | +23% | +$19,778 | ||||||
2018-03-09 | DXR | Daxor Corp | Feldschuh Joseph | 10% | S - Sale | $6.44 | -37,000 | 2,774,455 | -1% | -$238,280 | ||||||
2018-03-15 | DXR | Daxor Corp | Thompson Soren | VP | S - Sale | $19.54 | -2,950 | 950 | -76% | -$57,634 | ||||||
2018-03-15 | DXR | Daxor Corp | Feldschuh Michael Richard | Pres | S - Sale | $16.40 | -20,800 | 152,806 | -12% | -$341,120 | ||||||
2018-03-15 | DXR | Daxor Corp | Feldschuh Jonathan Adam | Dir | S - Sale | $18.63 | -19,194 | 3,908 | -83% | -$357,584 |
Real-time CSV? Options? Alerts? Contact us!
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |